GE HealthCare Technologies
$64.29Change from previous close: +0.48%Absolute change: +$0.31
At a glance
- Revenue growth
- +4.84%
- 2025 vs 2024
- Net income growth
- +4.57%
- 2025 vs 2024
- Net margin
- 10.1%
- 2024: 10.1%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total revenue | 20,625 | 19,672 | 19,552 | 18,341 | — |
| Cost of revenue | 12,378 | 11,467 | 11,630 | 11,162 | — |
| Gross profit | 8,247 | 8,205 | 7,922 | 7,179 | — |
| Selling, general and administrative | 4,225 | 4,269 | 4,282 | 3,631 | — |
| Research and development | 1,260 | 1,311 | 1,205 | 1,026 | — |
| Operating income | 2,762 | 2,625 | 2,435 | 2,522 | — |
| EBIT | 3,208 | 3,086 | 2,903 | 2,598 | — |
| EBITDA | 3,786 | 3,666 | 3,513 | 3,231 | — |
| Interest expense | 440 | 505 | 542 | 86.0 | — |
| Pre-tax income | 2,768 | 2,581 | 2,361 | 2,512 | — |
| Income tax | 614 | 531 | 743 | 563 | — |
| Net income | 2,084 | 1,993 | 1,568 | 1,916 | — |
| Net income to common shareholders | 2,084 | 1,993 | 1,385 | 1,916 | — |
| Basic EPS | 4.56 | 4.37 | 3.05 | 4.63 | — |
| Diluted EPS | 4.55 | 4.34 | 3.03 | 4.63 | — |
| Average shares (basic) | 456 | 456 | 455 | 414 | — |
| Average shares (diluted) | 458 | 459 | 458 | 414 | — |